Monday 14th February 2011 |
Text too small? |
Pharmacybrands Group is to buy the shares in Radius Pharmacy for $17.1 million, with an assumption of debt of $18 million, subject to net asset and other adjustments.
Pharmacybrands today said the agreement was conditional on the approval of its shareholders, who were expected to meet in late March, and completion of finance arrangements.
Radius Pharmacy holds interests in 34 pharmacies and has annual revenue around $86 million.
Pharmacybrands said Radius Pharmacy would be a strong fit with its existing business, strengthening its ability to invest in systems and other resources to enhance the services to pharmacies operating under its brands.
Retail competition was primarily from other channels and the company must invest in the tools and developing the skills to compete effectively, at the same time as investing in new service opportunities in primary care, Pharmacybrands chief executive Alan Wham said.
NZPA
No comments yet
2025 Annual Shareholders' Meeting and Director Nominations
Meridian Energy monthly operating report for July 2025
August 15th Morning Report
VGL upgrades aspirations, accelerates to meet client demand
August 14th Morning Report
VHP - Focus on Fundamentals: Driving Operational Performance
August 13th Morning Report
Devon Funds Morning Note - 12 August 2025
Spark announces sale of 75% of data centre business
Blackpearl Announces $15M Capital Raise & Market Update